Cargando…
Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H(2)O(2) production in heart and skeletal muscle mitochondria
Barth syndrome (BTHS) is a rare X‐linked genetic disorder caused by mutations in the gene encoding the transacylase tafazzin and characterized by loss of cardiolipin and severe cardiomyopathy. Mitochondrial oxidants have been implicated in the cardiomyopathy in BTHS. Eleven mitochondrial sites produ...
Autores principales: | Goncalves, Renata L. S., Schlame, Michael, Bartelt, Alexander, Brand, Martin D., Hotamışlıgil, Gökhan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894513/ https://www.ncbi.nlm.nih.gov/pubmed/33112430 http://dx.doi.org/10.1002/1873-3468.13973 |
Ejemplares similares
-
Loss of protein association causes cardiolipin degradation in Barth syndrome
por: Xu, Yang, et al.
Publicado: (2016) -
Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome
por: Petit, Patrice X., et al.
Publicado: (2020) -
Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype
por: Bowron, Ann, et al.
Publicado: (2014) -
Erratum to: Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype
por: Bowron, Ann, et al.
Publicado: (2015) -
Evaluation of cardiolipin nanodisks as lipid replacement therapy for Barth syndrome
por: Ikon, Nikita, et al.
Publicado: (2018)